Welcome back to another episode of Money Talk Sundayz w/ your Investment Bro Stevie Bee. Today I want to chat for a minute about another stock that I’m invested in that I’m real bullish about. Before popping that cherry though you got to wine and dine me. Hit that like and subscribe button if you want the goodies. If you’re feeling the podcast you can support the mission by clicking the link in the description box. You can also find the central hub for all of the MTS social media channels in the second link in the description box. Ok. I’m done. Let’s get to it.

Click for social media: https://linktr.ee/moneytalksundayz

Click to support the mission: https://anchor.fm/moneytalksundayz/support

Bros nation let’s talk Vaxart, ticket symbol VXRT. VXRT is a clinical-stage California-based biotechnology company focused on developing oral vaccines that are administered via tablet as opposed to injection. Vaxart's programs are based on its proprietary oral vaccine platform called VAAST. I stumbled onto this stock earlier this year because of the pandemic and the option of an oral vaccine it was in the process of manufacturing seemed pragmatic. As vaccinations ramp back up with the Delta variant running amok, the choice of taking a pill as opposed to getting a shot is very appealing. It’s oral tablet vaccine candidate is VXA-CoV2-1. Convenience alone would market this pill. I believed in the concept. So much so I bought shares of the company. And have been doing so regularly since May. Honestly it is the largest holding I have in my WeBull account.

Consider the advantages of using a tablet instead of a needle for a Covid-19 vaccine:

Convenient mode of administration

Rapid and painless

No needles required

Self-administration is possible – may eliminate the need to make appointments and stand in lines

Could reduce some people’s fear or hesitancy towards getting vaccinated

Vaxart’s pills can be stored at room temperature

Thus, Vaxart’s primary appeal is the pill.

But a Covid pill is not the only thing this company has to offer. In fact, it’s closer to something else than releasing the Covid pill. There is built-in value in VXRT beyond the anticipated Covid pill. The company’s anti-viral product portfolio is making exceptional progress lately. Vaxart could be not only a moneymaker, but also a lifesaver.

Let me elaborate.

VXRT has another drug in the pipeline, its clinical-stage, broad-spectrum anti-viral known as Vapendavir. The tablet addresses a host of conditions including:

Epidemic hand, foot and mouth disease

HRV infection in chronic obstructive pulmonary disease (COPD) patients

Enteroviral infections (mainly relating to children)

Seasonal recurrent lower respiratory tract infection in preschoolers

Seasonal asthma exacerbation in school-age children

Also, the company recently signed an agreement with Altesa Biosciences allowing Altesa to develop and commercialize Vapendavir.

Ok, so what’s VXRT doing today you might be wondering.

Well…

Vaxart, Inc. (Nasdaq: VXRT) today announced that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier.

The stock price of Vaxart Inc (NASDAQ: VXRT) increased by over 10% pre-market. Investors are responding positively to the company announcing that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier.

Welcome back to another episode of Money Talk Sundayz w/ your Investment Bro Stevie Bee. Today I want to chat for a minute about another stock that I’m invested in that I’m real bullish about. Before popping that cherry though you got to wine and dine me. Hit that like and subscribe button if you want the goodies. If you’re feeling the podcast you can support the mission by clicking the link in the description box. You can also find the central hub for all of the MTS social media channels in the second link in the description box. Ok. I’m done. Let’s get to it.

Click for social media: https://linktr.ee/moneytalksundayz

Click to support the mission: https://anchor.fm/moneytalksundayz/support

Bros nation let’s talk Vaxart, ticket symbol VXRT. VXRT is a clinical-stage California-based biotechnology company focused on developing oral vaccines that are administered via tablet as opposed to injection. Vaxart's programs are based on its proprietary oral vaccine platform called VAAST. I stumbled onto this stock earlier this year because of the pandemic and the option of an oral vaccine it was in the process of manufacturing seemed pragmatic. As vaccinations ramp back up with the Delta variant running amok, the choice of taking a pill as opposed to getting a shot is very appealing. It’s oral tablet vaccine candidate is VXA-CoV2-1. Convenience alone would market this pill. I believed in the concept. So much so I bought shares of the company. And have been doing so regularly since May. Honestly it is the largest holding I have in my WeBull account.

Consider the advantages of using a tablet instead of a needle for a Covid-19 vaccine:

Convenient mode of administration

Rapid and painless

No needles required

Self-administration is possible – may eliminate the need to make appointments and stand in lines

Could reduce some people’s fear or hesitancy towards getting vaccinated

Vaxart’s pills can be stored at room temperature

Thus, Vaxart’s primary appeal is the pill.

But a Covid pill is not the only thing this company has to offer. In fact, it’s closer to something else than releasing the Covid pill. There is built-in value in VXRT beyond the anticipated Covid pill. The company’s anti-viral product portfolio is making exceptional progress lately. Vaxart could be not only a moneymaker, but also a lifesaver.

Let me elaborate.

VXRT has another drug in the pipeline, its clinical-stage, broad-spectrum anti-viral known as Vapendavir. The tablet addresses a host of conditions including:

Epidemic hand, foot and mouth disease

HRV infection in chronic obstructive pulmonary disease (COPD) patients

Enteroviral infections (mainly relating to children)

Seasonal recurrent lower respiratory tract infection in preschoolers

Seasonal asthma exacerbation in school-age children

Also, the company recently signed an agreement with Altesa Biosciences allowing Altesa to develop and commercialize Vapendavir.

Ok, so what’s VXRT doing today you might be wondering.

Well…

Vaxart, Inc. (Nasdaq: VXRT) today announced that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier.

The stock price of Vaxart Inc (NASDAQ: VXRT) increased by over 10% pre-market. Investors are responding positively to the company announcing that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier.

Hey everyone and welcome to Money Talk Sundayz. I’m your investment bruv Stevie Bee. As I do these podcasts and segments I’m constantly trying to improve, incorporate new things, test things, all to better serve the viewers. Today’s segment is going to run longer than normal for the podcast but I may break it up into sections for the YouTube channel. With that being said, I have a lot to cover today from the latest “jump” in crypto from the possible Amazon cosign to market reactions from Chinese interference. So if any of these topics interest you, stick around for the latest market news and forecasts.

Support: https://linktr.ee/moneytalksundayz

Over the weekend crypto caught its second or third wind after running on fumes for the last couple months. News broke of an Amazon adoption for crypto that shot Bitcoin up from 31K to 38K and change. As we all know, as Bitcoin goes so does the rest of the crypto market proportionately.

BUT!

Not long after that news broke, Amazon came out and denied that it would accept bitcoin as payment.

Here are a couple money moves you can make to make your dollar stretch like elastic.

From Covid to the past election cycle and everything in between the news has been crazy and sensational. Now you can actually get paid for watching the news. Now you're not going to get rich quick. Hell you won't even get rich BUT every cent counts and every dollar you make you can take it and invest in the market, crypto, real estate or whatever other side hustle you have going on.

In market news tech stocks took a hit today. The sector in general ate a gut punch while the rest of the market dodged and weaved China’s breakdown. Both Nasdaq and the S&P 500 fell from record levels ahead of big tech earnings. For those that had that put option in play, I hope you got your money. Congratulations.

Overall, all three major stock indexes snapped their 5-day-winning streak buckling under the anticipation of quarterly results from some of the most prominent names in the tech sector as well as Chinese regulatory crackdowns looming.

Before I go I want to tell you a few of the companies that are reporting earnings this week. They are:

Apple

AMD (Advanced Micro Device

Microsoft

Google

Starbucks

Visa

Matttel

Norton Life Lock

Hawaiian Holdings

Paramount Group

Thanks for tuning into Money Talk Sundayz. I covered a lot of material in this episode. I hope you found some of it valuable. Again, please like, share and subscribe. Shoot me some feedback on what you’ve just heard. I enjoy hearing from you. I reply back to as many messages as I can. Don’t forget to check us out on Spotify and Apple Podcasts if you haven’t already. Subscribe to the YouTube page. You can click the link to take you to a central hub where you will find everything Money Talk Sundayz on social media. Let me hear from you. Until next time, the marathon continues.

Hey everyone and welcome to Money Talk Sundayz. I’m your investment bruv Stevie Bee. As I do these podcasts and segments I’m constantly trying to improve, incorporate new things, test things, all to better serve the viewers. Today’s segment is going to run longer than normal for the podcast but I may break it up into sections for the YouTube channel. With that being said, I have a lot to cover today from the latest “jump” in crypto from the possible Amazon cosign to market reactions from Chinese interference. So if any of these topics interest you, stick around for the latest market news and forecasts.

Support: https://linktr.ee/moneytalksundayz

Over the weekend crypto caught its second or third wind after running on fumes for the last couple months. News broke of an Amazon adoption for crypto that shot Bitcoin up from 31K to 38K and change. As we all know, as Bitcoin goes so does the rest of the crypto market proportionately.

BUT!

Not long after that news broke, Amazon came out and denied that it would accept bitcoin as payment.

Here are a couple money moves you can make to make your dollar stretch like elastic.

From Covid to the past election cycle and everything in between the news has been crazy and sensational. Now you can actually get paid for watching the news. Now you're not going to get rich quick. Hell you won't even get rich BUT every cent counts and every dollar you make you can take it and invest in the market, crypto, real estate or whatever other side hustle you have going on.

In market news tech stocks took a hit today. The sector in general ate a gut punch while the rest of the market dodged and weaved China’s breakdown. Both Nasdaq and the S&P 500 fell from record levels ahead of big tech earnings. For those that had that put option in play, I hope you got your money. Congratulations.

Overall, all three major stock indexes snapped their 5-day-winning streak buckling under the anticipation of quarterly results from some of the most prominent names in the tech sector as well as Chinese regulatory crackdowns looming.

Before I go I want to tell you a few of the companies that are reporting earnings this week. They are:

Apple

AMD (Advanced Micro Device

Microsoft

Google

Starbucks

Visa

Matttel

Norton Life Lock

Hawaiian Holdings

Paramount Group

Thanks for tuning into Money Talk Sundayz. I covered a lot of material in this episode. I hope you found some of it valuable. Again, please like, share and subscribe. Shoot me some feedback on what you’ve just heard. I enjoy hearing from you. I reply back to as many messages as I can. Don’t forget to check us out on Spotify and Apple Podcasts if you haven’t already. Subscribe to the YouTube page. You can click the link to take you to a central hub where you will find everything Money Talk Sundayz on social media. Let me hear from you. Until next time, the marathon continues.

If you’re here, you already know what time it is. Mind  your manners coming through the door and hit that Like button. It costs you less than a second to do it. I want to chop it up with you about a stock that I’m invested in that has been making quiet moves albeit very significant moves. You won’t find too much chatter about it surprisingly when you look at its growth over the past 12 months and its projected path. There are plenty of Bio tech stocks out there but this one is solid and continues to be so week to week month to month. That stock is Sesen Bio inc.

Support: https://linktr.ee/moneytalksundayz

Sesen Bio, or ticker symbol SESN, is up a whopping 417.72% over the last 12 months. It is currently trading at $4.13. I originally bought in at $2.96 back on May 26th of this year. In around a month and a half it’s approaching double its price. This is one of my long plays and quietly one of my favorites based upon it’s performance. The only downside in my opinion about this stock is that it doesn’t pay dividends so when my long play is over I will be dumping the stock and walking away with my profit. That is unless they switch it up and decide to pay dividends.

Across the market though, SESN is rated a strong buy. InvestorsObserver’s proprietary ranking system, gives SESN stock a score of 83 out of a possible 100. That rank is influenced by a long-term technical score of 98. SESN's rank also includes a fundamental score of 80.

Wall Street Zen as well as Tip Ranks also rate the stock a buy and are bullish about it. The general consensus is the same as far as the price target goes. All sources are in agreement at or around the $7-7.50 range. It is forecasted to hit that price mark in about 10-12 months. That gives you plenty of time to load up on shares and set your alerts for when it nears the price target to get ready to move out. But you will have to move fast.

So what is SESN and how is it doing in the news?

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. The company's lead product candidates include Vicinium, a locally-administered targeted fusion protein that is in phase 3 clinical trials for the treatment of high-risk non-muscle invasive bladder cancer (NMIBC); and VB6-845d, a systemically-administered product candidate for use in the treatment of various types of EpCAM-positive solid tumors. It also develops Vicinium in combination with Durvalumab, which is in Phase I clinical trials for use in the treatment of high-risk NMIBC; and Vicinium in combination with AstraZeneca's checkpoint inhibitor for the treatment of squamous cell carcinoma of the head and neck. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Today, Sesen Bio Inc (SESN) stock has risen 5.83% while the S&P 500 is up 0.65% as of 1:41 PM on Wednesday, Jul 21. SESN is up $0.23 from the previous closing price of $3.86 on volume of 3,254,475 shares. Over the past year the S&P 500 has risen 33.58% while SESN is up 417.72%. SESN's revenue has grown faster (73.99% per year) than the US market average (17.35%).

Institutions currently hold roughly 23% of the stock, 10% to insiders, and the rest to retail investors. Of the institutional investing, Vanguard Group Inc holds the most with 7,195,552 shares valued at $28.28 million.

Talk about M’s baby.

If you’re here, you already know what time it is. Mind  your manners coming through the door and hit that Like button. It costs you less than a second to do it. I want to chop it up with you about a stock that I’m invested in that has been making quiet moves albeit very significant moves. You won’t find too much chatter about it surprisingly when you look at its growth over the past 12 months and its projected path. There are plenty of Bio tech stocks out there but this one is solid and continues to be so week to week month to month. That stock is Sesen Bio inc.

Support: https://linktr.ee/moneytalksundayz

Sesen Bio, or ticker symbol SESN, is up a whopping 417.72% over the last 12 months. It is currently trading at $4.13. I originally bought in at $2.96 back on May 26th of this year. In around a month and a half it’s approaching double its price. This is one of my long plays and quietly one of my favorites based upon it’s performance. The only downside in my opinion about this stock is that it doesn’t pay dividends so when my long play is over I will be dumping the stock and walking away with my profit. That is unless they switch it up and decide to pay dividends.

Across the market though, SESN is rated a strong buy. InvestorsObserver’s proprietary ranking system, gives SESN stock a score of 83 out of a possible 100. That rank is influenced by a long-term technical score of 98. SESN's rank also includes a fundamental score of 80.

Wall Street Zen as well as Tip Ranks also rate the stock a buy and are bullish about it. The general consensus is the same as far as the price target goes. All sources are in agreement at or around the $7-7.50 range. It is forecasted to hit that price mark in about 10-12 months. That gives you plenty of time to load up on shares and set your alerts for when it nears the price target to get ready to move out. But you will have to move fast.

So what is SESN and how is it doing in the news?

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. The company's lead product candidates include Vicinium, a locally-administered targeted fusion protein that is in phase 3 clinical trials for the treatment of high-risk non-muscle invasive bladder cancer (NMIBC); and VB6-845d, a systemically-administered product candidate for use in the treatment of various types of EpCAM-positive solid tumors. It also develops Vicinium in combination with Durvalumab, which is in Phase I clinical trials for use in the treatment of high-risk NMIBC; and Vicinium in combination with AstraZeneca's checkpoint inhibitor for the treatment of squamous cell carcinoma of the head and neck. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Today, Sesen Bio Inc (SESN) stock has risen 5.83% while the S&P 500 is up 0.65% as of 1:41 PM on Wednesday, Jul 21. SESN is up $0.23 from the previous closing price of $3.86 on volume of 3,254,475 shares. Over the past year the S&P 500 has risen 33.58% while SESN is up 417.72%. SESN's revenue has grown faster (73.99% per year) than the US market average (17.35%).

Institutions currently hold roughly 23% of the stock, 10% to insiders, and the rest to retail investors. Of the institutional investing, Vanguard Group Inc holds the most with 7,195,552 shares valued at $28.28 million.

Talk about M’s baby.

What up Bros Nation. This your boy Stevie Bee coming back with another low cost option strategy you can use to triple and even quadruple your investment. Before we get started I need you guys to help me out. Hit that like and subscribe button. It helps the channel out tremendously. Also, if you’d like to be notified the moment a video drops hit that notification bell. Finally, you guys can check out the podcast on Spotify and support the movement by clicking the link (https://linktr.ee/moneytalksundayz) in the description box.   

Ok let’s get to it.   

So how can I 4 times my money and how much is it going to cost me? 

Remember  a couple weeks ago I did a video on tripling your money with the Long Call Condor Spread? If you didn’t see that video pause this video and go to the Money Talk Sundayz channel and check it out or click this link (https://youtu.be/flHYDWsdCCU?t=562).   

The method is similar to the previous one but in this instance we are doing only PUT options. It is called the Long Put Condor Spread. Here is how it works. You want to select a stock that has been moving reliably for the past month or so roughly about a half a point to a point either up or down. So yes… we are dealing with stock that is moving sideways. A good example of that would be Apple stock. From month to month the stock price has moved steadily about a point and a half or so. Not volatile at all.   

You don’t want to use this strategy on volatile stocks!  

Again, you do not want to use this strategy on volatile stocks!  

Moving on.   

Once you have your stock selected it’s time to move on to your favorite trading app and put in the option play. Keep in mind this play is all put options. With that being said:  

Step 1: Go to the options screen in your app and select Put. First thing we’re going to do is sell 2 puts.  

Step 2: Select the sell put option right above the share price.   

Step 3: Select the sell put option right above the previous put option.   

Step 4. Switch over to the Buy option and select the buy put option right above the previous sell put option selected.   

Step 5. Select the buy put option directly below the stock share price.   

And you’re done.   

Once you have those options selected, you’ll be able to see your max loss and max profits. As you can see your max loss is only the amount it cost you to make the play. On the flip side your max profit is 4 times or a little more than the money invested to make the play.   

And just like that you’ve managed to still create income in a sideways market.   

I hope you enjoyed this information and found it useful. If you did, please drop a like and subscribe. Leave a comment and let me know how it worked out for you. Now you don’t have to sit around and watch your portfolio tread water for weeks in a sideways market. You can now still make steady gains even while the market seems stagnant.   

This has been Stevie Bee. Thanks for tuning in to the Money Talk Sundayz Channel with your Investment bro. I look forward to sharing more new tidbits that come my way with you all. Together we can do this. Let’s make the most of this market and get what’s ours. If you have a request for a how-to video let me know in the comments or dm me. Your video might be the next one I do! Until next time, the marathon continues.

What up Bros Nation. This your boy Stevie Bee coming back with another low cost option strategy you can use to triple and even quadruple your investment. Before we get started I need you guys to help me out. Hit that like and subscribe button. It helps the channel out tremendously. Also, if you’d like to be notified the moment a video drops hit that notification bell. Finally, you guys can check out the podcast on Spotify and support the movement by clicking the link (https://linktr.ee/moneytalksundayz) in the description box.   

Ok let’s get to it.   

So how can I 4 times my money and how much is it going to cost me? 

Remember  a couple weeks ago I did a video on tripling your money with the Long Call Condor Spread? If you didn’t see that video pause this video and go to the Money Talk Sundayz channel and check it out or click this link (https://youtu.be/flHYDWsdCCU?t=562).   

The method is similar to the previous one but in this instance we are doing only PUT options. It is called the Long Put Condor Spread. Here is how it works. You want to select a stock that has been moving reliably for the past month or so roughly about a half a point to a point either up or down. So yes… we are dealing with stock that is moving sideways. A good example of that would be Apple stock. From month to month the stock price has moved steadily about a point and a half or so. Not volatile at all.   

You don’t want to use this strategy on volatile stocks!  

Again, you do not want to use this strategy on volatile stocks!  

Moving on.   

Once you have your stock selected it’s time to move on to your favorite trading app and put in the option play. Keep in mind this play is all put options. With that being said:  

Step 1: Go to the options screen in your app and select Put. First thing we’re going to do is sell 2 puts.  

Step 2: Select the sell put option right above the share price.   

Step 3: Select the sell put option right above the previous put option.   

Step 4. Switch over to the Buy option and select the buy put option right above the previous sell put option selected.   

Step 5. Select the buy put option directly below the stock share price.   

And you’re done.   

Once you have those options selected, you’ll be able to see your max loss and max profits. As you can see your max loss is only the amount it cost you to make the play. On the flip side your max profit is 4 times or a little more than the money invested to make the play.   

And just like that you’ve managed to still create income in a sideways market.   

I hope you enjoyed this information and found it useful. If you did, please drop a like and subscribe. Leave a comment and let me know how it worked out for you. Now you don’t have to sit around and watch your portfolio tread water for weeks in a sideways market. You can now still make steady gains even while the market seems stagnant.   

This has been Stevie Bee. Thanks for tuning in to the Money Talk Sundayz Channel with your Investment bro. I look forward to sharing more new tidbits that come my way with you all. Together we can do this. Let’s make the most of this market and get what’s ours. If you have a request for a how-to video let me know in the comments or dm me. Your video might be the next one I do! Until next time, the marathon continues.

How is it going Bros’ nation? Welcome back to another episode. Today I want to chat for a bit about CLF, Cleveland Cliffs Inc. I stumbled across this stock today and I saw something promising, and I thought I would share. Before getting into it though, hit that like, share, and subscribe so new folks can be introduced to what we are doing here at Bros nation. I took a little family vacay, but I am back, and I have some extra free time on my hands due to quarantine so…. Market watching and playing is my focus until this quarantine is over. FYI I am covid negative for those that are wondering.   

Support: https://linktr.ee/moneytalksundayz 

Anyway, on to CLF.  

It is currently ranked a strong buy on Tip Ranks with a prospective price target of 29.62 at the mid-range. On the high end its priced at $39 and $24 on the low end. Currently it is trading at 19.10. This morning  the stock saw “unusual options activity” according to Benzinga. Now unusual options activity can be triggered by one of three things: 1. Exceptionally large trading volume which refers to the number of contracts traded over a given amount of time. 2. The trading of a contract with an expiration date in the distant future also marks unusual activity. Generally speaking, when it comes to options the farther out the expiration date of the contract, the higher the potential for  it to reach the strike price and grow its time value. Time value in this respect is important because it represents the difference between the strike price and the value of the underlying asset. And finally, 3. Out of the money contracts are considered unusual because the contracts are purchased with a strike price that is far from the underlying asset price. Buyers and sellers attempt to take advantage of a large profit margin in these cases because they are banking on the value of the underlying asset to change dramatically in the future.

With these signatures coming into play, one would be hard pressed not to at least add this stock to their watch list. Its next earnings report date is this Thursday the 22nd. If I were to run an option play, I would probably play a call option and sell it right before close Wednesday afternoon.

Why?  

Wall Street expects a year-over-year increase in earnings on higher revenues when Cleveland-Cliffs (CLF) reports results for the quarter ended June 2021. While this widely known consensus, outlook is  important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.  The earnings report, which is expected to be released on July 22, 2021, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it is worth handicapping the probability of a positive EPS surprise. Considering that I just transferred funds to my Webull account this morning, those funds are not available for options trading I am playing the long swing trade and purchased a significant number of shares to hold until I reach my target price before selling. CLF does not currently pay dividends, so I will not need to buy and hold this stock so once my swing trade is over, its on to the next play. One thing I am trying to do is clear the clutter that I have made with all the different stocks that I have plays in now. I am holding on to all my dividend paying stocks but for all the others, once I have made my profit, I am dumping them until another play presents itself.

How is it going Bros’ nation? Welcome back to another episode. Today I want to chat for a bit about CLF, Cleveland Cliffs Inc. I stumbled across this stock today and I saw something promising, and I thought I would share. Before getting into it though, hit that like, share, and subscribe so new folks can be introduced to what we are doing here at Bros nation. I took a little family vacay, but I am back, and I have some extra free time on my hands due to quarantine so…. Market watching and playing is my focus until this quarantine is over. FYI I am covid negative for those that are wondering.   

Support: https://linktr.ee/moneytalksundayz 

Anyway, on to CLF.  

It is currently ranked a strong buy on Tip Ranks with a prospective price target of 29.62 at the mid-range. On the high end its priced at $39 and $24 on the low end. Currently it is trading at 19.10. This morning  the stock saw “unusual options activity” according to Benzinga. Now unusual options activity can be triggered by one of three things: 1. Exceptionally large trading volume which refers to the number of contracts traded over a given amount of time. 2. The trading of a contract with an expiration date in the distant future also marks unusual activity. Generally speaking, when it comes to options the farther out the expiration date of the contract, the higher the potential for  it to reach the strike price and grow its time value. Time value in this respect is important because it represents the difference between the strike price and the value of the underlying asset. And finally, 3. Out of the money contracts are considered unusual because the contracts are purchased with a strike price that is far from the underlying asset price. Buyers and sellers attempt to take advantage of a large profit margin in these cases because they are banking on the value of the underlying asset to change dramatically in the future.

With these signatures coming into play, one would be hard pressed not to at least add this stock to their watch list. Its next earnings report date is this Thursday the 22nd. If I were to run an option play, I would probably play a call option and sell it right before close Wednesday afternoon.

Why?  

Wall Street expects a year-over-year increase in earnings on higher revenues when Cleveland-Cliffs (CLF) reports results for the quarter ended June 2021. While this widely known consensus, outlook is  important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.  The earnings report, which is expected to be released on July 22, 2021, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it is worth handicapping the probability of a positive EPS surprise. Considering that I just transferred funds to my Webull account this morning, those funds are not available for options trading I am playing the long swing trade and purchased a significant number of shares to hold until I reach my target price before selling. CLF does not currently pay dividends, so I will not need to buy and hold this stock so once my swing trade is over, its on to the next play. One thing I am trying to do is clear the clutter that I have made with all the different stocks that I have plays in now. I am holding on to all my dividend paying stocks but for all the others, once I have made my profit, I am dumping them until another play presents itself.